pSivida: Out-licensing of BioSiliconTM to PureTech Development LLC
Through a range of collaborative partnerships and internal R&D over the last four years, pSivida has developed the BioSiliconTM (nano-structured porous elemental silicon) technology platform in non-core areas such as tissue engineering, wound management and orthopedics to a point where it is in a position and in line with the Company's broader commercialization strategy, to seek suitable partners in these specialist areas of healthcare.
pSivida has commissioned PureTech to explore with suitable partners, arrangements for evaluating the potential of BioSiliconTM in their areas of expertise and such partnerships would be expected to produce, in due course, revenue in the form of upfront and milestone payments as BioSiliconTM based products are developed and commercialized.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.